BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 31470593)

  • 1. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
    Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).
    Vizzuso S; Del Torto A; Dilillo D; Calcaterra V; Di Profio E; Leone A; Gilardini L; Bertoli S; Battezzati A; Zuccotti GV; Verduci E
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Visceral Adiposity Index Levels in Predicting the Presence of Metabolic Syndrome and Insulin Resistance in Overweight and Obese Patients.
    Pekgor S; Duran C; Berberoglu U; Eryilmaz MA
    Metab Syndr Relat Disord; 2019 Jun; 17(5):296-302. PubMed ID: 30932744
    [No Abstract]   [Full Text] [Related]  

  • 4. Association Between the Visceral Adiposity Index and Homeostatic Model Assessment of Insulin Resistance in Participants With Normal Waist Circumference.
    Ji B; Qu H; Wang H; Wei H; Deng H
    Angiology; 2017 Sep; 68(8):716-721. PubMed ID: 28743220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.
    Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
    Qing L; Wei R; Chan L; Xiaoya Z; Xin X
    J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of visceral adiposity index in predicting metabolic syndrome in adults with obstructive sleep apnea: a cross-sectional study.
    Chen GP; Qi JC; Wang BY; Lin X; Zhang XB; Zhao JM; Chen XF; Lin T; Chen DD; Lin QC
    BMC Pulm Med; 2016 Mar; 16():37. PubMed ID: 26931776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the ability of HOMA-IR, VAI, and TyG indexes to predict metabolic syndrome in children with obesity: a cross-sectional study.
    Dundar C; Terzi O; Arslan HN
    BMC Pediatr; 2023 Feb; 23(1):74. PubMed ID: 36765298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and Visceral Adiposity Index in non-functional adrenal adenomas.
    Karatas S; Hacioglu Y; Beysel S
    Arch Endocrinol Metab; 2023 Mar; 67(3):323-329. PubMed ID: 36468929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
    Hernández MJG; Klünder M; Nieto NG; Alvarenga JCL; Gil JV; Huerta SF; Siccha RQ; Hernandez J
    Endocr Pract; 2018 Mar; 24(3):294-301. PubMed ID: 29547047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals.
    Barazzoni R; Gortan Cappellari G; Semolic A; Ius M; Zanetti M; Gabrielli A; Vinci P; Guarnieri G; Simon G
    Clin Nutr; 2019 Jun; 38(3):1171-1179. PubMed ID: 29779870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
    Wang H; Cao H; Cao J; Zhang L
    Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does visceral adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical inflammation.
    Al-Daghri NM; Al-Attas OS; Alokail M; Alkharfy K; Wani K; Amer OE; Ul Haq S; Rahman S; Alnaami AM; Livadas S; Kollias A; Charalampidis P; Sabico S
    Pediatr Res; 2014 Mar; 75(3):459-63. PubMed ID: 24296798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of a new anthropometric indicator - VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome.
    Brończyk-Puzoń A; Jagielski P; Kulik-Kupka K; Koszowska A; Nowak J; Zubelewicz-Szkodzińska B
    Adv Clin Exp Med; 2017 Aug; 26(5):825-828. PubMed ID: 29068579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
    Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
    Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waist-to-height ratio: an accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients.
    Silva MI; Lemos CC; Torres MR; Bregman R
    Nutrition; 2014 Mar; 30(3):279-85. PubMed ID: 24332526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients.
    Fahmy AM; El Shall N; Kabbash I; El Ahwal L; Selim A
    Endocr Regul; 2023 Jan; 57(1):99-105. PubMed ID: 37183690
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
    Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
    J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.